Press

FILTER:
Endpoints News • April 11, 2025

Replacing Animal Testing with Organoids

Newly-installed FDA Commissioner Marty Makary announced a plan to begin phasing out animal testing in drug development, particularly for monoclonal antibodies, but how long will it take?
Read More
Inc. Magazine • April 4, 2025

The Trade War Is On. Is This 3-D Printing’s Moment?

What if, instead of buying your parts from abroad, there was a simpler way to manufacture at home without building a factory. That’s the solution seen by advocates of additive manufacturing, more colloquially known as 3-D printing. Instead of buying parts from a foreign country, additive enthusiasts ask, why not print them in the U.S.?
Read More
Boston Globe • March 25, 2025

Boston Globe Media’s New England’s Fastest Growing Companies 2025

We’re proud to have been named to Boston Globe Media's New England’s Fastest Growing Companies 2025! It’s great to represent the 3D printing space as we continue to work to enable innovation across industries. Here’s to our fellow New Englanders on this list – congratulations!
Read More
3D Printing Industry • March 17, 2025

3D Printing Industry -Executive Survey

Our CEO John Kawola is in good company in 3D Printing Industry’s 2025 Executive Survey, sharing his thoughts on the future of 3D printing and how AI will impact additive manufacturing. As our industry continues to evolve, John sees an expanded need for materials compatibility in the short term and how 3D printing is uniquely positioned to solve society’s big problems in the long term.
Read More
Medical Design & Outsourcing • March 11, 2025

Three Predictions for High-Precision 3D Printing and Innovation

Steady customer growth, new materials and applications, U.S. Food and Drug Administration (FDA) 510(k) clearance for innovative UltraThineer™ material, commercialization in global dental markets and industry’s first line of hybrid micro 3D printers fueled growth in 2024.
Read More
Med Tech • March 8, 2025

Using 3D printing for drug delivery innovation

Steady customer growth, new materials and applications, U.S. Food and Drug Administration (FDA) 510(k) clearance for innovative UltraThineer™ material, commercialization in global dental markets and industry’s first line of hybrid micro 3D printers fueled growth in 2024.
Read More